Osilodrostat (Isturisa): Clinical Trials

1 trial of Osilodrostat (Isturisa), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow Osilodrostat (Isturisa): new trials by email Literature Review of Osilodrostat (Isturisa) trials Research Report on Osilodrostat (Isturisa)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
Osilodrostat (Isturisa) - Mild Autonomous Cortisol Secretion (MACS)
Phase 4RecruitingJohns Hopkins University102026-02-022026-03-05

Conditions studied

ACTH Syndrome, Ectopic (1)  ·  Adrenal Hyperplasia, Congenital (1)  ·  Hypertension (1)

Sponsors

Johns Hopkins University (1)

Countries

United States (1)

Top investigators

Amir Hamrahian, MD (1)

Results publications

PMID 27454103, PMID 28887710, PMID 29510982, PMID 30817193, PMID 31206616, PMID 35220871, PMID 3536461, PMID 35817047, PMID 36952249, PMID 37318239, PMID 37801655, PMID 39062179, PMID 39086899, PMID 6135282